Franklin Resources’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$376M Sell
6,198,167
-2,352,990
-28% -$137M 0.09% 203
2025
Q4
$461M Sell
8,551,157
-151,013
-2% -$7.26M 0.11% 185
2025
Q3
$392M Buy
8,702,170
+265,359
+3% +$12.4M 0.1% 202
2025
Q2
$391M Buy
8,436,811
+4,961,869
+143% +$244M 0.1% 196
2025
Q1
$212M Buy
3,474,942
+2,454
+0.1% +$143K 0.06% 291
2024
Q4
$196M Sell
3,472,488
-91,365
-3% -$5.1M 0.05% 306
2024
Q3
$188M Sell
3,563,853
-2,213,071
-38% -$104M 0.05% 310
2024
Q2
$240M Sell
5,776,924
-5,795,122
-50% -$259M 0.07% 255
2024
Q1
$628M Buy
11,572,046
+2,214,847
+24% +$113M 0.2% 130
2023
Q4
$480M Buy
9,357,199
+2,510,134
+37% +$132M 0.22% 108
2023
Q3
$397M Buy
6,847,065
+1,524,631
+29% +$93.4M 0.2% 124
2023
Q2
$340M Buy
5,322,434
+1,569,932
+42% +$105M 0.16% 160
2023
Q1
$260M Buy
3,752,502
+989,027
+36% +$69.8M 0.13% 195
2022
Q4
$199M Sell
2,763,475
-5,957,437
-68% -$449M 0.1% 227
2022
Q3
$620M Sell
8,720,912
-3,378,854
-28% -$245M 0.34% 68
2022
Q2
$932M Sell
12,099,766
-3,822,933
-24% -$291M 0.46% 48
2022
Q1
$1.16B Buy
15,922,699
+2,338,579
+17% +$157M 0.46% 47
2021
Q4
$847M Sell
13,584,120
-376,253
-3% -$22.1M 0.31% 79
2021
Q3
$826M Sell
13,960,373
-1,867,872
-12% -$123M 0.31% 86
2021
Q2
$1.06B Sell
15,828,245
-3,640,181
-19% -$237M 0.4% 60
2021
Q1
$1.23B Buy
19,468,426
+5,172,488
+36% +$322M 0.5% 45
2020
Q4
$887M Buy
14,295,938
+5,062,692
+55% +$311M 0.38% 65
2020
Q3
$557M Buy
9,233,246
+1,772,127
+24% +$107M 0.27% 95
2020
Q2
$447M Sell
7,461,119
-82,447
-1% -$4.93M 0.23% 116
2020
Q1
$420M Sell
7,543,566
-2,382,366
-24% -$146M 0.28% 95
2019
Q4
$637M Sell
9,925,932
-5,832,550
-37% -$334M 0.33% 82
2019
Q3
$799M Buy
15,758,482
+398,031
+3% +$18.7M 0.43% 60
2019
Q2
$697M Buy
15,360,451
+9,507,798
+162% +$443M 0.37% 71
2019
Q1
$279M Buy
5,852,653
+4,591,269
+364% +$229M 0.15% 185
2018
Q4
$65.6M Buy
1,261,384
+558,475
+79% +$30M 0.04% 434
2018
Q3
$43.6M Sell
702,909
-3,239,216
-82% -$192M 0.02% 576
2018
Q2
$218M Buy
3,942,125
+2,425,602
+160% +$131M 0.11% 217
2018
Q1
$95.9M Sell
1,516,523
-1,978,598
-57% -$127M 0.05% 370
2017
Q4
$214M Sell
3,495,121
-2,721,850
-44% -$170M 0.1% 224
2017
Q3
$396M Buy
6,216,971
+118,036
+2% +$6.89M 0.19% 142
2017
Q2
$340M Buy
6,098,935
+3,960,191
+185% +$215M 0.17% 161
2017
Q1
$116M Buy
2,138,744
+248,180
+13% +$13.6M 0.06% 325
2016
Q4
$110M Buy
1,890,564
+338,461
+22% +$18.5M 0.06% 317
2016
Q3
$83.7M Sell
1,552,103
-1,009,955
-39% -$64.9M 0.04% 388
2016
Q2
$188M Sell
2,562,058
-5,326,455
-68% -$376M 0.1% 225
2016
Q1
$504M Sell
7,888,513
-383,056
-5% -$24.2M 0.27% 106
2015
Q4
$569M Sell
8,271,569
-2,351
-0% -$155K 0.29% 101
2015
Q3
$490M Buy
8,273,920
+2,844,359
+52% +$180M 0.24% 114
2015
Q2
$361M Buy
5,429,561
+1,054,010
+24% +$69.5M 0.16% 152
2015
Q1
$282M Sell
4,375,551
-81,474
-2% -$5.1M 0.13% 186
2014
Q4
$263M Sell
4,457,025
-71,108
-2% -$4.01M 0.12% 195
2014
Q3
$232M Buy
4,528,133
+465,271
+11% +$23.2M 0.11% 211
2014
Q2
$197M Buy
4,062,862
+1,949,806
+92% +$96.1M 0.09% 246
2014
Q1
$110M Buy
2,113,056
+68,040
+3% +$3.62M 0.05% 351
2013
Q4
$109M Sell
2,045,016
-26,793
-1% -$1.36M 0.05% 346
2013
Q3
$95.9M Sell
2,071,809
-1,275
-0.1% -$56K 0.05% 358
2013
Q2
$92.6M Buy
+2,073,084
New +$90M 0.05% 337

Other funds holding BMY

Franklin Resources's BMY Position: Q1 2026 in Review

Franklin Resources reduced its Bristol-Myers Squibb (BMY) stake by 28% in Q1 2026, selling an estimated $137M and leaving 6,198,167 shares worth $376M. The position accounts for 0.09% of the portfolio, ranked #203.

Franklin Resources first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.23B in Q1 2021. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Franklin Resources held 6,198,167 shares of Bristol-Myers Squibb worth $376M as of Q1 2026.
  • Franklin Resources sold 2,352,990 Bristol-Myers Squibb shares in Q1 2026, an estimated $137M.
  • Bristol-Myers Squibb made up 0.09% of Franklin Resources's portfolio in Q1 2026, its #203 holding.
  • Franklin Resources first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Franklin Resources's Bristol-Myers Squibb position peaked at $1.23B in Q1 2021.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.